Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia - Test2 - elhamkhani - TriplyDB

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

http://www.wikidata.org/entity/Q34746995

about

Biomarkers in dementia: clinical utility and new directions An update on semantic dementia: genetics, imaging, and pathology Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease.CSF neurofilament light chain reflects corticospinal tract degeneration in ALS.Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes.Neurofilament light chain: a biomarker for genetic frontotemporal dementia Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.Imaging and fluid biomarkers in frontotemporal dementia.The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials.Applying fluid biomarkers to Alzheimer's disease.Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration.Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases Frontotemporal dementia with a C9ORF72 expansion in a Swedish family: clinical and neuropathological characteristics.Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression Disease modification and Neuroprotection in neurodegenerative disorders.Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.Somatic complaints in frontotemporal dementia.CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers.Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.Plasma neurofilament light chain concentration in the inherited peripheral neuropathies.Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.Molecular biomarkers of Alzheimer's disease: progress and prospects.Biomarkers in frontotemporal dementia Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients

P2860

Q27007086-C8AA7FC9-358B-48FC-9206-859A673EE7A9 Q28069807-9A89947D-1166-4B52-A2A0-BC447E1E94AB Q30224292-AC8D32D7-D77A-465A-B299-78CE723E076F Q33610029-68D465C2-4F10-48F4-8C0E-189AFB6C10EC Q34776835-AC650877-21D7-430D-9525-78171D20BBC3 Q35093695-0BB3EC6B-D128-4430-814B-1C8473E2DF9F Q35848870-4F4A8F1A-C00A-4D44-BEAC-044CA4A1BC42 Q35935100-34D55443-D23F-43B1-B3F4-7077776D8533 Q36913222-51279DFC-E71B-4374-9CB1-18B6336FA378 Q36933708-FCC94E4E-BEEE-43D3-972F-58FF1DA1A04E Q37208495-0EA68276-D2D6-4C05-B192-9742A4D11C54 Q37304614-005C1AA5-1183-4D9B-B3B6-10D6CE4AF438 Q37307467-D7CBCD78-A77F-4993-A278-68D920E020F8 Q37690301-B0DC87D5-D0C9-4EA4-84D4-0CD8B0D09020 Q37703133-CF741DCD-86BD-475E-939E-F467044B0FCC Q38392505-34473500-05E7-48F8-9B4F-E45560067477 Q38670219-FBB1D738-1C41-40C6-803F-5A4D786A0A9B Q38672062-85695A50-AFC2-4526-B15B-9E782FAE2A68 Q39251035-6E75DEFC-F67F-431A-B2EE-4B2D97E2793C Q39339614-14959EEF-CEE1-4A68-BEE9-A216916BE844 Q41518367-F629424B-BEDE-4266-8A2B-116C6C6050B4 Q41849494-1E29434E-50CF-47FB-83E6-98FAB1D38C0F Q42287644-8DFE3C1F-C5BE-44C4-8C7F-D7961B55A37B Q42363882-7F8FAE52-00C1-46EC-BEA8-C208A0EBD5BB Q42656279-EE60C333-E29D-44C1-A7CA-AA517649E58D Q42875256-760861F4-8C57-4D1C-8C78-DDE43431C1E8 Q47315423-A82C555E-4D5F-420D-A833-8D8C8D72E386 Q47341318-486AFA57-A1E1-4EA1-B2F0-B0241C2149F9 Q47587631-73F09330-E26D-40D3-8E5E-12220213863D Q47819962-1314CFE5-8A1F-487B-91A9-4360E2E72D36 Q48168855-E09DBF54-F562-4D87-A52E-E08680483DEF Q48265513-154C299E-6F8A-4781-AD12-8A95E87A4C3F Q50102118-37755B4B-76BE-4463-BEA3-BA9624BEFCA7 Q52646410-DC1E68F7-024D-4C70-B41D-E76DB448DF30 Q53396239-C526B2B1-5979-4475-AEB0-84CACC65A6A1 Q53430039-64D0EEBC-5074-475D-9BB4-25F9D459A324 Q54946040-E94E08DF-480B-4CE3-BB25-C15E336E1CCC Q57911950-4F9D53E2-82E3-4C05-A9DA-57867F24D5E6 Q58780665-50D52155-18BF-4D51-BDFE-A53291A6F312

P2860

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

http://www.wikidata.org/entity/Q34746995

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@ast

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@en

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@nl

type

label

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@ast

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@en

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@nl

prefLabel

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@ast

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@en

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@nl

P1433

Q34746995-9EB20BC1-BC8D-4272-8426-7551F1A1804B

P1476

Q34746995-A7869C59-942C-4A3F-8560-875B79402534

P2093

Q34746995-0AF8C38C-F69B-42C5-B477-63C747F207E8

Q34746995-0B7B9FC3-82E4-4F25-B9B9-3E09EF9FB487

Q34746995-4A516CEF-9AB2-4E77-AA52-61F732D07FA4

Q34746995-AC1BCC9F-0EE9-414E-A1BC-04264B6ABB55

P2860

Q34746995-005E4D7A-4916-4BD6-8BB3-9085954FFB30

Q34746995-075EF99A-AE4F-45B4-BC1A-CD1443AED832

Q34746995-10CBBB98-40D3-4A6F-8CC5-0CFE80FAF3E9

Q34746995-14F692C7-2D1D-4FCB-A0C8-368748102CE3

Q34746995-1562EB45-9ED4-4F60-847D-7CC4E7AC1117

Q34746995-20A8C296-13F6-4C3B-BFE1-9AB7C1ACA0C4

Q34746995-211DB138-128C-4C45-95D7-A84539D9B316

Q34746995-41C2A856-F1D6-4803-ABBC-73A4F1E3927E

Q34746995-46937A1F-8AA1-4E49-92F0-E6012F57924E

Q34746995-4A7AC4DF-97D6-4A58-8627-AA9E9151187A

P2888

Q34746995-D54F9E59-2C9A-45B9-B2C1-32C6CD4FAE85

P304

Q34746995-F5AD25DB-239A-43B5-9595-111E1BFCFC2E

P31

Q34746995-DFAEEA11-0763-4AFF-B6F4-8C360E0F1412

P356

Q34746995-96109377-780E-4276-97CC-6D2ACD363A30

P478

Q34746995-B0EE9FBB-BDD7-4F6E-9D68-DE0C9673F261

P50

Q34746995-931435C0-6119-48F9-BA2E-A480087391E6

Q34746995-CBD073DB-DBC6-4470-92A8-840476528E2E

Q34746995-D0B4869B-8471-402E-9758-EB86154C41F8

P577

Q34746995-F73D19C5-D4A4-4458-A4D0-DDE15AD31377

P5875

Q34746995-94B3915A-E3B2-4D0B-8772-4D1171DFEC04

P6179

Q34746995-379E453E-CA0B-4EDD-A758-1CE34D1B6BEE

P698

Q34746995-432EABE8-BCB7-4E1E-A16C-3C23CB3086DB

P921

Q34746995-952C5C61-F327-44B3-A762-DF3BCCDC4DDB

Q34746995-B958ED58-D220-4F46-91CF-676F25AB3536

P932

Q34746995-D9FE0620-2757-4E99-AD24-BF8CEB67DA45

P356

1471-2377-13-54

P1433

P1476

Cerebrospinal fluid neurofilam ...... pes of frontotemporal dementia

@en

P2093

Alexander Frizell Santillo

http://www.w3.org/2001/XMLSchema#string

Christer Nilsson

http://www.w3.org/2001/XMLSchema#string

Maria Landqvist Waldö

http://www.w3.org/2001/XMLSchema#string

Ulla Passant

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of primary progressive aphasia and its variants

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease

A new subtype of frontotemporal lobar degeneration with FUS pathology

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.

Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.

CSF neurofilament proteins in the differential diagnosis of dementia

P2888

1471-2377-13-54

P304

54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2377-13-54

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Elisabet Englund

Henrik Zetterberg

P577

2013-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236967117

http://www.w3.org/2001/XMLSchema#string

P6179

1049074002

http://www.w3.org/2001/XMLSchema#string

P698

23718879

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

3671150

http://www.w3.org/2001/XMLSchema#string